NICE recommends Xolair for allergic asthma

The U.K.'s NICE recommended the use of Xolair omalizumab from Novartis (NVS; SWX:NOVN) and Genentech (DNA) on the National Health Service (NHS) as an add-on to standard therapy to treat severe persist...